The COVID-19 vaccine from Pfizer currently holds the title of Big Pharma’s most successful medication ever.
Pfizer made $36.8 billion in 2021 thanks to the investigational mRNA gene treatment.
If the FDA is given the go-ahead by the dishonest FDA, another potential injection might shatter that record.
Some analysts predict that Eli Lilly’s tirzepatide will generate sales of more than $50 billion in its first year.
Tirzepatide, marketed under the trade name Mounjaro, is an injection-only weight-loss medication.
The weight-loss injection from Eli Lilly would be the best-selling medication ever if sales follow expectations.
According to experts, it is currently accessible off-label to individuals seeking weight loss.
Big pharma's golden ticket: Sales of new weight-loss shot made by Eli Lilly forecast to hit $50BILLION this year – which would make it the best-selling drug of all time
via https://t.co/t7Lq79y5hK https://t.co/eCP7rMXHEs— Prof Imonokha Enakhena PhD (@IEnakhena) January 3, 2023
Daily Mail reported:
Analysts expect the drug — which is believed to be better than similar rival medications — to make anywhere from $25 to $48billion in the US in its first year.
That’s more than the current record holder, Pfizer’s Covid jab, which raked in $36.8billion in 2021, and more than double the $20.7 billion set by AbbVie’s rheumatoid arthritis drug Humira in the same year.
It comes after Wegovy – a similar fat-melting shot – was approved for obese children as young as 12.
Tirzepatide is already approved as a diabetes drug and is currently available off-label for weight-loss patients.
It is administered to patients as a weekly injection, which can be done at home.
The drug then works by binding to receptors for two appetite-regulating hormones — GLP-1 and GIP — sending signals to the brain that the body is full.
It also slows down the stomach’s ability to clear food, partly by reducing the amount of acid produced by the stomach, helping people feel fuller for longer.
It differs from Wegovy — made by the Danish company Novo Nordisk — because it mimics the effects of two hormones, whereas Wegovy only copies GLP-1.
Studies have indicated that tirzepatide is the most effective weight loss medication that has ever been available.
Yale University’s Dr Ania Jastreboff, who led clinical trials of the drug, heralded tirzepatide as ‘much more highly effective than any other medications we’ve had for the treatment of obesity’.
A phase three clinical trial involving 2,500 obese and overweight adults found tirzepatide slashed their bodyweight by a fifth in 72 months.
Big Pharma advocates an injection to encourage weight loss instead of physical activity, a wholesome diet, sunlight, herbs, enough sleep, water intake, and other healthy lifestyle modifications.
Big Pharma depends on sick and unwell people to boost profits.
Because a healthy population means that this heinously corrupt sector of the economy collapses.
Leave a Comment